Medicines and Mental Health Notices




16 NOVEMBER 2006 NEW ZEALAND GAZETTE, No. 137

4003

Product: Octanate
Active Ingredient: Factor VIII, human 250IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturers: Octapharma Pharmazeutika Produktionsges, Vienna, Austria
Octapharma, Lingolsheim, France

Product: Octanate
Active Ingredient: Factor VIII, human 500IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturers: Octapharma Pharmazeutika Produktionsges, Vienna, Austria
Octapharma, Lingolsheim, France

Dated this 10th day of November 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7945

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Humira
Active Ingredient: Adalimumab 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Wasserburger Arzneimittelwerk GmbH, Wasserburg, Germany

Dated this 10th day of November 2006.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7946

Mental Health (Compulsory Assessment and Treatment) Act 1992

Mental Health (Compulsory Assessment and Treatment) Act Notice 2006—Appointment of a Director of Area Mental Health Services

Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Stephen Bruce McKernan, Director-General of Health, give the following notice.

Notice

  1. This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”).
  2. The Schedule to the principal notice is amended in respect of

“Area 6—Taranaki”

by omitting the name and title

“David John Bruce, registered nurse of New Plymouth”

and substituting the name and title

“Dr Allan Binnie, psychiatrist, of New Plymouth.”

Dated at Wellington this 7th day of November 2006.

STEPHEN BRUCE MCKERNAN, Director-General of Health.

New Zealand Gazette, 31 August 2000, No. 117, page 2963

go7935

Mental Health (Compulsory Assessment and Treatment) Act Notice 2006—Appointment of a Director of Area Mental Health Services

Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Stephen Bruce McKernan, Director-General of Health, give the following notice.

Notice

  1. This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”).
  2. The Schedule to the principal notice is amended in respect of

“Area 8—Manawatu–Wanganui”

by omitting the name and title

“Dr Andrew Aston, medical practitioner of Feilding”

and substituting the name and title

“Ian Michael Charles Brown, registered nurse, of Palmerston North.”

Dated at Wellington this 7th day of November 2006.

STEPHEN BRUCE MCKERNAN, Director-General of Health.

New Zealand Gazette, 31 August 2000, No. 117, page 2963

go7936



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 137


Gazette.govt.nz PDF NZ Gazette 2006, No 137





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
10 November 2006
Medicines Act, New Medicines, Octanate, Factor VIII, Human, Powder for Injection, Diluent, Octapharma New Zealand Limited, Octapharma Pharmazeutika Produktionsges, Vienna, Austria, Octapharma, Lingolsheim, France
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Consent to the Distribution of a Changed Medicine

🏥 Health & Social Welfare
10 November 2006
Medicines Act, Changed Medicine, Humira, Adalimumab, Solution for Injection, Abbott Laboratories (NZ) Limited, Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany, Wasserburger Arzneimittelwerk GmbH, Wasserburg, Germany
  • DON MATHESON, Deputy Director-General, Public Health

🏥 Appointment of a Director of Area Mental Health Services for Taranaki

🏥 Health & Social Welfare
7 November 2006
Mental Health, Compulsory Assessment and Treatment Act, Director of Area Mental Health Services, Taranaki, New Plymouth, Registered Nurse, Psychiatrist
  • David John Bruce (Registered Nurse), Removed as Director of Area Mental Health Services for Taranaki
  • Allan Binnie (Doctor), Appointed as Director of Area Mental Health Services for Taranaki

  • Stephen Bruce McKernan, Director-General of Health

🏥 Appointment of a Director of Area Mental Health Services for Manawatu–Wanganui

🏥 Health & Social Welfare
7 November 2006
Mental Health, Compulsory Assessment and Treatment Act, Director of Area Mental Health Services, Manawatu–Wanganui, Feilding, Palmerston North, Medical Practitioner, Registered Nurse
  • Andrew Aston (Doctor), Removed as Director of Area Mental Health Services for Manawatu–Wanganui
  • Ian Michael Charles Brown (Registered Nurse), Appointed as Director of Area Mental Health Services for Manawatu–Wanganui

  • Stephen Bruce McKernan, Director-General of Health